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Key questions
What is already known?
 ► There has been huge global success in reducing the 
burden of leprosy using multidrug therapy to treat 
leprosy.
 ► Progress towards stopping discrimination and pro-
moting inclusion of people affected by leprosy has 
not kept pace with medical advances.
 ► There is an increasing interest in understanding 
the processes underlying stigmatisation of leprosy 
among programme implementers and research-
ers, though many stigma studies ignore the moral 
experiences of people affected by leprosy and the 
influence of sociocultural contexts on stigmatisation.
What are the new findings?
 ► This study provides rich contextualised under-
standings of Yorùbá ideas of leprosy, illuminating 
how culture and wider social factors such as social 
structures, policies and contact with Western mis-
sionaries shape people’s diverse experiences and 
responses to leprosy-related stigma.
What do the new findings imply?
 ► The findings can contribute to better understanding 
of the sources and implications of leprosy-related 
stigma and to providing evidence for decision-mak-
ing and practice among the Yorùbá people.
AbsTrACT
Introduction Renewed interest in health-related stigma 
has invigorated calls to understand factors and processes 
underlying stigma. However, few empirical studies explore 
the influences of structural discrimination and moral status 
on leprosy-related stigma. We investigated how sociocultural 
context and organisational policies and practices influenced 
the connotations of leprosy, sources of stigma and the 
changing social responses to leprosy in Western Nigeria.
Methodology Ethnographic research conducted between 
2008 and 2012 combined documents review with life 
history interviews of 21 individuals affected by leprosy and 
semistructured interviews with 26 community members in 
Western Nigeria. Interviews were audiotaped, transcribed 
verbatim and coded. Theoretical frameworks used to 
deepen social understandings of leprosy and responses to 
stigma included Link’s and Phelan’s conceptualisation of 
stigma and the concepts of structural discrimination and 
moral status.
results Findings showed that connotations of leprosy 
in Yorùbá culture included the following: (i) perception of 
leprosy as the most shameful and detested condition and 
(ii) symbolic association with filth and immoral behaviour 
that is dishonouring to Yorùbá identity. Secondary analysis 
of archival materials revealed four sources of stigma: 
cultural beliefs about leprosy, health promotion messages 
embedded in primary school books, religious teachings 
about leprosy and campaigns conducted by the leprosy 
service in 1950s. Contrary to the portrayal of Yorùbá 
attitudes to leprosy as entirely negative, we identified that 
people affected by leprosy were creating new life courses 
to counter existing cultural accounts of marginalisation. 
Emerging narratives of inclusion outlined five facilitators 
of acceptance namely, antileprosy treatment, good moral 
character, supportive family networks, livelihoods, and 
contribution to community survival.
Conclusion Gaps highlighted by this study suggest that the 
global target of zero stigma and discrimination of leprosy 
will remain unattainable without better understanding of 
cultural significance(s) of leprosy and the local sources and 
underlying drivers of stigma that are crucial for developing 
context-specific stigma reduction interventions.
InTroduCTIon
Leprosy has been associated with stigmatisa-
tion throughout history despite being one of 
the least contagious of infectious diseases.1–3 
The disease is characterised by skin lesions 
and peripheral nerve damage that may lead 
to skin ulceration and physical deformities. 
Since the introduction of antibiotic multi-
drug therapy (MDT) for leprosy treatment in 
the 1980s, the number of new diagnosed cases 
has decreased, and leprosy was even declared 
eliminated as a public health problem at a 
global level in the year 2000, that is, <1 case 
per 10 000 people.4 Subsequently, global 
leprosy strategies have focused on reducing 
disease burden measured in terms of new 
cases with visible deformities.4 In keeping 
with this, the targets of the global leprosy 
strategy 2016–2020 ‘Accelerating towards a 
leprosy-free world’ include the following: 
(i) zero visible disabilities among children 
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and (ii) zero stigma and discrimination while ensuring 
that countries repeal discriminatory laws.5 However, 
scholars have contended that these targets are difficult to 
achieve in the near future and that leprosy will continue 
to impose huge burdens of disability and stigmatisation 
in many endemic countries6 7 with weak health systems. 
Consistent with these concerns, the global number of 
new diagnosed cases has remained above 200 000 annu-
ally for the last decade, due, in part, to continuing stigma-
tisation and inadequate resources that hinder diagnosis 
and treatment of leprosy and perpetuate the spread of 
leprosy.5
Renewed emphasis on social aspects of leprosy has 
invigorated investigations into factors and processes 
underlying leprosy-related stigma. Some scholars have 
explored the causes and consequences of leprosy-re-
lated stigma8 9 or specific aspects such as concealment of 
leprosy.10 11 Other scholars developed and validated tools 
to measure stigma or its proxies in different settings.12 13 
However, many stigma studies in Nigeria have focused on 
surveying the knowledge, attitudes and practices (KAP) 
of health workers, students and the public in south-
eastern, northern and the middle belt of Nigeria, partly 
due to the ease of access to these groups of stakeholders. 
Overall, many of the studies showed mixed results. While 
some researchers blamed stigmatising attitudes on low 
levels of leprosy awareness of respondents,14–17 others 
argued that high levels of awareness among health 
workers and students were unmatched by positive atti-
tudes.18 19 Although KAP surveys and using validated 
tools to measure stigma are important in their own right, 
Kleinman and Hall-Clifford argue that the first focus of 
the efforts to counteract stigma should be directed at 
exploring the underlying social and cultural processes 
of stigmatisation in the live worlds of the stigmatised.20 
Kleinman and Hall-Clifford argue that ethnographic 
methods are better suited to unravelling the local value 
systems and what matters most in the live worlds of stig-
matised groups, compared with using standard survey 
instruments.
Nigeria detects 3500 new leprosy cases annually, 25% 
of whom suffer some impairment.21 There are significant 
geographical differences in the distribution of leprosy in 
Nigeria with notification rates higher in the North than 
in the South, and higher in the East than in the West of 
Nigeria.22 Those affected by leprosy continue to experi-
ence intense stigma and discrimination,23 particularly in 
Western Nigeria, home to the Yorùbá people. While we 
focus on Nigeria, the population of the Yorùbá in West 
Africa is estimated to be over 43 million, making them 
one of the largest groups in sub-Saharan Africa. Their 
main concentration is in southwest Nigeria where they 
number approximately 40 million (or 21% of Nigeria’s 
population), occupying seven of Nigeria’s 36 States: Ekiti, 
Lagos, Kwara, Ogun, Ondo, Osun and Oyo.24p35 However, 
despite being one of the largest groups in sub-Saharan 
Africa, little is known about the anthropology of leprosy 
among the Yorùbá people. This paper therefore explores 
the influence of cultural context and organisational poli-
cies and practices on the moral definition of leprosy and 
its stigma among the Yorùbá in Western Nigeria. The 
paper follows a reanalysis of transcripts of lived experi-
ences of leprosy, conducted as part of an ethnographic 
study of the sources, severity and persistence of stigma 
in Western Nigeria, a part of which has been reported 
elsewhere.25 That preliminary report (https:// doi. 
org/ 10. 1080/ 13696815. 2012. 704263) highlighted two 
key findings. First, it showed that the context in which 
people affected by leprosy found themselves in Western 
Nigeria was saturated in metaphorical language. That 
article documented how disease metaphors were used to 
codify and express Yorùbá understandings about leprosy. 
Second, it highlighted that information concerning 
Yorùbá understanding of leprosy (ie, about its causes, 
transmission, symptoms, treatment and cure) was lacking 
from the international literature. This paper fills the 
identified knowledge gap by answering three research 
questions: What are the moral connotations and social 
expectations regarding leprosy in Western Nigeria; what 
are the perceptions of symptoms and signs, causes and 
treatment of leprosy among the Yorùbá people and to 
what extent has stigmatisation of leprosy changed in 
Western Nigeria?
We begin by elaborating the methods used including 
the study design, data collection and theoretical models 
that informed data analysis. Our findings are presented 
according to six broad themes: (i) connotations to leprosy, 
(ii) causes and transmission of leprosy, (iii) the sources of 
stigma, (iv) Yorùbá perception of treatment and cure, (v) 
help-seeking for leprosy and (vi) the changing stigmatisa-
tion of leprosy. The views and experiences of people with 
leprosy and community members are elaborated, under-
lining those that are relevant for stigma reduction and 
achieving the global target of zero stigma and discrimi-
nation. We conclude by comparing our findings to social 
responses to leprosy in India, in Mali, West Africa and in 
Tanzania, East Africa.
MeTHods
study design
This study adopted a qualitative, retrospective narrative 
life course design to understand how leprosy shaped the 
lives of affected persons in Western Nigeria. Life course 
research is the study of social processes that extend 
over an individual’s life span, or significant portions of 
it, especially relating to their family cycle, educational 
and training histories, as well as employment and occu-
pational careers.26 Among other things, life course is 
shaped by cultural beliefs about the individual biography, 
institutionalised sequences of roles and positions, legal 
role restrictions and decisions of individual actors. A life 
course approach therefore aims to (i) provide better 
descriptions and explanations of life events and social 
patterns of life trajectories within a common conceptual 
and empirical frameworks; (ii) represent the processes 
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that shape these events and trajectories and (iii) link 
these processes together and identify societal change or 
dynamics. For this study, life course experiences of living 
with leprosy incorporated the events and social patterns 
of the life trajectories of individuals affected by leprosy, 
beginning from the periods before leprosy diagnosis, 
extending through treatment for leprosy and discharge 
from treatment, to the moment they participated in the 
study.
study setting, target population and research team
Our ethnographic study was implemented in Kwara and 
Oyo States that lie to the west and southwest, respectively, 
of Nigeria’s capital, Abuja. Kwara and Oyo were selected 
because they had not participated in stigma studies prior 
to our research. A leprosy settlement in each state served 
as study sites, as most people with leprosy resided in 
settlements. A recent count suggests approximately 1600 
people live in settlements in the two states with 768 (48%) 
of them having visible impairment. Residents of leprosy 
settlements were mainly traders, farmers and hospital 
workers. The samples for the study were as follows: (i) indi-
viduals affected by leprosy who had completed a course of 
antileprosy treatment and resided in leprosy settlements 
in the study area and (ii) community members who did 
not have leprosy, purposively selected to provide infor-
mation on the meanings and sociocultural perceptions of 
leprosy, and Yorùbá responses to leprosy. To capture the 
variations in community views, participants were purpo-
sively selected by age, gender, religion and their occupa-
tion or role in the community.
Two research assistants, who were community-based 
rehabilitation workers at the study sites, approached 
potential participants (face-to-face) to explain the study 
objectives and distribute participant information sheets 
(in local language), to help them to decide to participate 
(or not) in the study. To minimise the possibility of coer-
cion, potential participants were then approached by a 
research assistant 2 days after explaining the research 
objectives and invited to participate in the study. Research 
assistants also obtained permission from heads of leprosy 
settlements to implement the study. The assistants 
received a 3-day introduction to social research and the 
life course approach, followed by a 2-day pilot study to 
check study feasibility and appropriateness of interview 
questions in Yorùbá culture. Interviews were conducted 
in Yorùbá language by BE and GA, who were male, post-
graduate sociologists experienced in stigma research.
data collection
Data collection consisted of document reviews and 
in-depth interviews with research participants. Three 
types of documents and texts provided a rich source of 
information for the study. First, historical materials from 
books and published articles downloaded from major 
databases of medical and social sciences. Second, leprosy 
control policies, records and reports on the organisation 
and implementation of leprosy control. Third, archival 
records from leprosy referral hospitals, the libraries of 
universities and voluntary agencies to illuminate the 
influence of institutional practices on leprosy-related 
stigma in Nigeria.27–29
Only one potential participant declined to participate 
in the study. Semistructured interviews were conducted 
in two phases of fieldwork, to unravel how people made 
sense of their experiences of and responses to leprosy 
and stigma across the life course in Western Nigeria. 
During phase 1 (September and October 2009), 36 semi-
structured interviews were conducted: 21 with people 
affected by leprosy in their homes, and 15 with commu-
nity members aged ≥40 years. Individuals affected by 
leprosy, interviewed for 30–45 min per person, were 
asked to reflect on their life histories and how living 
with leprosy and its stigma influenced their life trajecto-
ries including how leprosy affected family relationships, 
educational and training histories, as well as occupa-
tions. On the other hand, community members, inter-
viewed for 15–20 min per person, were asked about the 
local notions of leprosy, and attitudes and responses to 
leprosy and affected persons. Phase 2 fieldwork (August 
2010 to January 2011) served two main purposes. First, 
to conduct 11 additional semistructured interviews with 
community members aged <40 years (at their workplaces 
or schools) to investigate aspects of leprosy and stigma 
that emerged from analysis of phase 1 interviews. Second, 
using structured vignettes30 to crosscheck our interpre-
tation of phase 1 interviews with research participants, 
that is, member checking.30 31 In all, 12 of 36 partici-
pants interviewed in phase 1 were selected for member 
checking (seven affected individuals and five community 
members). The 12 participants were purposively selected 
to illuminate issues raised in the vignettes.
data analysis
All interviews were audio-recorded, transcribed verbatim 
and coded for manual analysis. During coding, BE and 
GA organised segments or paragraphs of data into 
‘chunks’ before assigning meanings to chunks. The 
chunks of material were then labelled by research ques-
tion and categorised with a term based on the actual 
language of study participants. The research involved a 
process of concurrent interviewing, constant comparative 
analysis, interpretation and reflection on research ques-
tions and data collected, asking analytic questions, and 
writing reflexive memos throughout the study. A reanal-
ysis of archival materials and interview transcripts that 
informed this article was undertaken between January 
and July 2017.
reflexivity
BE, GA and BO were born in Western Nigeria and 
had extensive engagement with the study region, both 
as researchers (BE and GA) and as global health prac-
titioners (BE and BO). These roles aided our under-
standing of the sociocultural context of Western Nigeria 
and enhanced awareness of, and sensitivity to the 
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challenges, decisions and issues encountered in the 
study region. The roles also facilitated working with 
research participants and informants during the study. 
These previous experiences and insight from the litera-
ture meant that we brought certain biases to the study. 
Although every effort has been made to ensure objec-
tivity, we admit that these biases have shaped our experi-
ences of this study and the way that we viewed and under-
stood the data collected and interpreted. This reflexivity 
guided the analysis and discussion of study finding in the 
rest of this paper thesis.
Theoretical models of stigma that informed data analysis
In framing our study of stigma, we drew on a number of 
theoretical models that help to account for social, cultural 
and material contexts of interaction.32–35 Goffman 
argued that stigma is embedded in relationships rather 
attributes, stating that stigma occurs when the construc-
tion of social categories is linked to stereotypical beliefs 
that label and distinguish people or groups for being 
different or unacceptable, thereby ‘spoiling their social 
identity’.32 According to Goffman, stigmatised persons 
either internalised the prevailing negative beliefs about 
their identities and reputations or resisted stigma by 
using cover-up strategies such as stories to deflect atten-
tion from tainted identities. Extending Goffman’s idea of 
relationships, contemporary stigma theories argue that 
stigmatisers exploit situations of unequal power within 
their sociocultural environment to control, regulate or 
exclude others for breaching social norms or expec-
tations.34 36 Link and Phelan regard stigma as a social 
construction that occurs when the processes of labelling, 
negative stereotyping, exclusion, discrimination and 
low status coexist in a power situation that facilitates the 
manifestation of these processes.34Using a dimensional 
conceptualisation of stigma, Jones et al37 described six 
dimensions that influenced societal responses to stigma. 
The dimensions are as follows: (i) ‘concealability’—
perception that the degree of visibility of a difference is 
linked to the severity of stigmatisation; (ii) ‘peril’—the 
perception that the stigma is threatening to others or 
has the potential for contagion; (iii) ‘chronicity’—condi-
tions with longer duration/courses attract severer stigma 
compared with conditions that are of shorter duration; 
(iv) ‘disruptiveness’—the extent to which a difference 
interferes with smooth social interaction; (v) aesthetics—
the potential for a condition to induce a disgust reaction 
and (vi) ‘origin’—the perception that a stigma is caused 
deliberately, unintentional or present at birth.38 Scholars 
have used Jones et al’s framework to examine how each 
of these six dimensions affected stigmatisers’ perception 
of stigmatised individuals, with concealability and origin 
receiving the most empirical attention.39
To elucidate the processes of institutional stigma, 
Corrigan et al40 adopted the theory of structural discrim-
ination (ie, ways in which institutional policies and/or 
practices may constrain people’s rights and opportuni-
ties) to investigate access to mental health treatment for 
disadvantaged groups. Besides institutional policies and 
legislations, Yang et al revealed that structural discrimi-
nation can also manifest through local cultural processes 
that interact with structural forces to create context-re-
lated dynamics of stigma and health inequities,41p85. Yang 
et al used Kleinman's concept of ‘moral experience’ of 
culture to investigate ‘what matters most’ to individuals 
who inhabit local social worlds.42 The concept of ‘moral 
experience’ or ‘what matters most’ for stakeholders in a 
local social world’ provides a new theoretical model for 
explaining the social responses of stigmatisers and stig-
matised alike.43 Yang and colleagues argue that culture 
influences stigma by threatening the ability of individuals 
to participate in the activities that govern ‘what matters 
most’ within a cultural context. The authors discov-
ered that ‘what mattered most’ to ordinary individuals 
included, but not limited to, achieving status, health, 
money, relationships, livelihoods and religious experi-
ence. As stigma constrains the capability of individuals 
to participate in or uphold ‘what matters most’, stigma-
tised individuals (or their associates) are likely to lose 
their moral statuses and be excluded from local groups. 
This interdependence of moral status (and social capital) 
to stigma suggests44 the importance of their analysis for 
understanding the sources and consequences of lepro-
sy-related stigma.
We therefore used the stigma models of Yang et al 
(2014), Corrigan et al (2005) and Link and Phelan (2001, 
2004) to analyse the experiences of people with leprosy, 
to unravel how Yorùbá people stigmatised leprosy and 
people living with leprosy. Specifically, we used Yang 
et al’s concept of moral status to investigate how socio-
cultural connotations of leprosy impacted on the social 
status of those affected by leprosy, and the Yorùbá iden-
tity. Second, we used Corrigan et al’s concept of struc-
tural discrimination to understand how disease control 
policies and religious practices interacted with cultural 
perceptions of leprosy to influence stigmatisation. Third, 
we used Link’s and Phelan’s concept of power differen-
tials to explore whether the exclusion of people affected 
by leprosy was permanent and to identify contextual facil-
itators of inclusion among the Yorùbá people.
resulTs
A total of 59 interviews were conducted with 47 partic-
ipants (21 affected by leprosy and 26 community 
members). In all, 36 interviews (61%) were conducted 
during phase 1 of fieldwork and the remaining 23 inter-
views (39%) during phase 2. The 21 participants affected 
by leprosy were aged 35 to 90 years; 11 were women. 
One of the 11 women and 8 of the 10 men were literate. 
Community member participants were aged 18 to 78 
years; 6 (23%) were women; all were literate. Tables 1 
and 2 summarise demographic characteristics of partici-
pants affected by leprosy and community member partic-
ipants, respectively.
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Table 1 Demographic characteristics of participants 
affected by leprosy
Characteristics
Value 
(n=21)
Age range (years) 35–90
Female 11 (52%)
Literate (ie, at least primary education) 9 (43%)
Employed (trader, farmer, civil servant, etc) 19 (90%)
Visible physical impairment 16 (76%)
Muslim 7 (33%)
Christian 14 (67%)
Table 2 Demographic characteristics of community 
member participants
Characteristics
Value 
(n=26)
Age range (years) 19–78
Female 6 (23%)
Literate 26 (100%)
Employed 18 (69%)
Visible physical impairment 0 (0%)
Muslim 4 (15%)
Christian 22 (85%)
See online supplementary appendixes 1 and 2 for 
additional details on demographic characteristics of 
participants.
Connotations and significance of leprosy
The Yorùbá word ẹ̀tẹ̀ usually translates as leprosy. Ẹ́tẹ̀ is 
used to describe the light-coloured or reddish patches on 
the surface of the skin and the distinguishable deformi-
ties of the hands and feet of people affected by leprosy.45 46 
A synthesis of the diverse community perspectives identi-
fied three key connotations of leprosy among the Yorùbá 
people.
The leading connotation was the intense shame and 
disgrace associated with leprosy. The word for shame 
in Yorùbá is ẹ̀tẹ́ which appears to be same as the word 
for leprosy (ẹ̀tẹ̀) except for the slight difference in 
orthographical symbols on the second syllable of the 
two words to reflect the variation in pronunciation of 
the terms. Related to shame was the discrediting image 
of leprosy in Western Nigeria. Community members 
commented that, ‘leprosy destroys a person’s name 
and reputation’ (Ẹ́tẹ̀ dúró fún ìbani l’órúko jẹ́). Everyone 
interviewed for this research indicated that associating 
leprosy with immoral behaviour discredited not just 
the people affected by leprosy, it collectively tainted the 
Yorùbá people. Commenting on the moral significance 
of leprosy, a Muslim cleric said the following:
Leprosy is a dreadful disease that is comparable to being 
cloaked with shame (Àrùn tó dàbí wípé wợ́n ko àbùkù bo ènìyàn 
ni). It is regarded as a disease of shame…Anything that is 
associated with shame is detested by Yorùbá people. In fact, 
leprosy is the most detestable of detested conditions…The 
Yorùbá detest anything that tarnishes their reputation and 
leprosy tarnishes people’s reputation. That is why leprosy 
is detested (Bàbá Túndé (Contributions by participants 
of this research are anonymized by masking the names of 
respondents, places and activities. The people interviewed 
are referred to by pseudonyms to protect their identities), 
Male, Cleric).
The above account suggests that the degree of stig-
matisation of a condition is related to the extent that 
the condition discredits an individual’s reputation or 
threatens cultural identity. By using a cloak of shame as a 
metaphor for leprosy, this interview extract implies that 
leprosy completely overshadows an individual’s repu-
tation and by extension threatens societal identity in a 
culture that idolises moral character. Labelling leprosy as 
most contemptible in Yorùbá culture also implies that it 
will attract the harshest stigmatisation. Internalising the 
above ‘grid of meanings’ about leprosy will undoubtedly 
provoke a feeling that those with leprosy bring shame on 
their families and communities.
Leprosy was also associated with filth, a connotation 
that seemingly originated from a Yorùbá religious belief 
that socialising with unhygienic persons tarnished the 
reputation of religious priests. Based on their religious 
training, Yorùbá priests were expected to avoid people 
with leprosy to safeguard their religious status:
The Yorùbá are scrupulous about self-hygiene. People who 
are meticulous about personal hygiene hate filth. The 
Yorùbá believe that leprosy is a filthy disease. From a reli-
gious point of view, it is believed filth tarnishes the spiritual 
status of a worshipper. So, the Yorùbá people have learned 
to avoid things that tarnish their reputation. This is the ba-
sis of the norm of avoidance of people affected by leprosy 
(Bàbá Onílè, Male Traditional Ruler).
The above quote illustrates how religious traditions 
can shape contemporary beliefs that socialising with 
affected people produces courtesy stigma, thus triggering 
a general avoidance of people with leprosy.
Causation and transmission of leprosy
We identified two broad ideas of causation of leprosy in 
Yorùbá culture: supernatural and natural causes. Most 
community members and persons affected by leprosy 
claimed leprosy was more likely to be caused via supernat-
ural affliction than by natural means. Although the idea of 
supernatural causation was dominant in Western Nigeria, 
respondents also indicated that belief in natural causa-
tion was gaining popularity, especially following decades 
of public health campaigns and treatment of leprosy 
in Yorùbá towns. The demographic characteristics of 
respondents revealed a generational split in perception, 
with most people aged 18–39 years reporting that leprosy 
was contracted through natural causes while those aged 
40–80 years believed leprosy was a supernatural condi-
tion deliberately inflicted on a person by sorcery.
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The range of natural causes of leprosy cited by respon-
dents revolved around four themes. The majority of 
community members believed leprosy was hereditary, 
passed down from parents to their children in families 
that were susceptible to the disease. Another popular 
view was that leprosy was caused by air–droplet infec-
tion, transmitted to people living with affected persons 
in poorly ventilated houses. Most of those who believe 
in air–droplet infection were aged 18–39 years. Less 
popular modes of natural causation included casual 
contact with skin lesions and ulcers; and the sharing of 
cups, plates and bedding with persons suffering from 
leprosy.
sources of stigma in Western nigeria
For this study, sources of stigma refer to the places, 
persons, social processes, institutional practices etc., from 
which the public learn about and/or imbibe negative 
stereotypes and discriminatory attitudes. Our sociolog-
ical understanding of stigma suggests the ways in which 
people react to illness or disease are strongly linked to 
broader social and cultural processes. We therefore 
reviewed archival documents for clues of discriminatory 
institutional policies and social practices that potentially 
shaped community perceptions and social reactions to 
leprosy in Western Nigeria. Our analysis identified three 
dimensions of institutional responses to leprosy. First, 
examples of messages disseminated from 1930s onwards 
by missionaries through Christian churches that were 
intended to counter traditional beliefs about leprosy 
stated the following:
Leprosy is not caused by some juju or curse put upon a 
person…It should be regarded as a disease which can be 
passed from one person to another as smallpox, yet taking 
months or years to develop instead of days.29
Although affected persons were previously ‘looked upon 
as unclean’ [i.e. unhygienic], there was no need to ‘fear 
them because they cannot give you the disease unless you 
intimately live with them or handle their open wounds’.29
Second, health promotion messages embedded in 
primary school books (first published in the 1940s and still 
used by children aged 9–10 years) included information 
on ‘taboos’ and ‘behavioural prohibitions’, such as not 
sharing food, kitchen utensils and beddings with people 
affected by leprosy47p74-76. The continuing endorsement 
of these books and the persistence of leprosy-related 
taboos in the memories of teenagers interviewed for this 
study contribute to our understanding of the social prac-
tices in Western Nigeria. Third, we identified a twofold 
format poster–leaflet commissioned by the government 
in 1955 to raise awareness about the ‘danger’ posed by 
leprosy.48 The lower half of the poster–leaflet (figure 1) 
depicted that it was dangerous to have casual contact 
with or share beddings and dishes with people affected 
by leprosy.49
It is plausible that depicting leprosy as a ‘dangerous’ 
and contagious disease continues to influence discrim-
inatory ideas and practices towards leprosy in Western 
Nigeria.
Perspectives on symptoms and signs of leprosy
While most people affected by leprosy were knowledge-
able about the symptoms and signs of leprosy, they, 
however, did not associate the early symptoms and signs 
of their illness with the biomedical condition. Instead, 
they attributed the early symptoms and signs to other 
common skin diseases, for example, ringworm, eczema 
and nettle rash, perhaps because the general community 
only recognises leprosy when someone has deformities 
and/or inflamed reddish skin lesions.
Help-seeking by affected persons
Analysis of help-seeking behaviours of people affected by 
leprosy suggested a hierarchical pathway of help-seeking, 
with most affected persons starting with self-treatment, 
followed by consulting traditional healers and finally 
consulting churches and/or Western medical practi-
tioners. Only 2 of 21 participants affected by leprosy 
consulted traditional healers and faith healing before 
they were referred to a leprosy hospital. The domi-
nance of supernatural causation in this culture meant 
that the primary help-seeking pathway for most people 
was consulting traditional healers followed ultimately 
by referrals to a hospital. As only two people reported 
using faith healing alone or in combination with tradi-
tional medicine, faith healing was considered an alterna-
tive help-seeking pathway for this research. There was a 
tendency to alternate between traditional medicine and 
treatment at a general hospital; or between traditional 
medicine and faith healing before eventual referral for 
treatment in a leprosy hospital.
Many of those who visited traditional healers reported 
consulting up to five different traditional healers before 
leaving them for a leprosy hospital. While our sample was 
purposively selected so that quantitative measures may 
be heavily biassed, it is informative to note that partici-
pants’ total delay arising from self-treatment, consulting 
traditional healers and/or faith healers ranged from 3 
months to 25 years before referral to a leprosy hospital 
for treatment. Women respondents were more likely to 
delay diagnosis and treatment. The link between stigma, 
delayed help-seeking and gender are highlighted in the 
discussion section.
Cultural understanding of treatment and cure
In explaining the difference between treatment and cure, 
the following quote describes the normative expectations 
of ‘sickness behaviour’ in Yorùbá culture:
When a person is ill, they are expected to submit them-
selves for care and during this process of care they are 
given some medicament. It is the receipt of this medica-
ment that we call treatment. Without receiving the medica-
ment, they cannot progress to a cure. If they do not take 
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Figure 1 Poster–leaflet used in Western Nigeria in 1950s.
the treatment, they will not be cured. Concerning leprosy, 
we can tell when someone is taking treatment, because we 
notice changes or differences in their body. For instance, 
if they had visible skin signs, these signs will begin to clear 
as they take their treatment. And we know that they are 
cured when their skin signs have completely disappeared, 
and they also feel well. So, cure is the complete removal of 
the signs of the disease from their body and blood. (Male, 
Farmer affected by leprosy)
This narrative captures the expected sequence of events 
starting from patients consulting or presenting themselves 
to a competent caregiver, to how they receive/are given 
medicaments to make the sick person better, through to 
completion of process of care indicated by the complete 
resolution of all visible signs of disease and perhaps, 
laboratory evidence of undetectable germs. Commu-
nity member participants were emphatic that leprosy 
was treatable though a few people doubted that leprosy 
was completely curable. They implied the equivalence of 
‘being treatable’ with the ability of Western medicine to 
kill leprosy bacilli and render affected persons noninfec-
tious. An account supporting this viewpoint asserts the 
following:
Yes, leprosy is treatable to the extent that the disease is 
no longer in the body, but we know that the deformities 
caused by leprosy cannot be restored. The Yorùbá belief 
is that although leprosy is treatable, it is not completely 
curable. It is not completely curable because for instance, 
those who have deformities of the hands and feet cannot 
have their deformed fingers and toes restored to the nor-
mal state after medical treatment. Although it is possible 
to heal ulcers, we believe the fact that visible deformities 
cannot be restored means that leprosy is not completely 
curable (Bàbá Túndé, Male cleric).
Despite awareness of the efficacy of MDT to render 
affected persons noninfectious, Bàbá Túndé’s account 
of cure refers to complete reversal of all signs of leprosy 
 o
n
 8 M
arch 2019 by guest. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2018-001250 on 7 March 2019. Downloaded from 
8 Ebenso B, et al. BMJ Glob Health 2019;4:e001250. doi:10.1136/bmjgh-2018-001250
BMJ Global Health
to their pre-disease state when neither skin lesions nor 
impairment are visible. This Yorùbá notion of cure is at 
variance with the biomedical understanding within global 
leprosy guidelines that interchanges the terms ‘treatment’ 
and ‘cure’ to indicate completion of a full course of MDT 
regardless of residual impairment50p30. The biomed-
ical understanding is based on laboratory evidence that 
MDT renders the patient noninfectious within a few days 
of starting of treatment, that is, reducing viable leprosy 
germs in the body to undetectable levels.51 The narratives 
in this section have implications for acceptance of those 
who have completed a course of antileprosy therapy in 
the community.
The changing stigmatisation of people with leprosy in 
Western nigeria
A combination of community perceptions suggested that 
acceptance in Yorùbá denoted that ‘a person affected by 
leprosy is unreservedly welcomed back into the commu-
nity after completing antileprosy therapy; accorded their 
due dignity and respect; and granted the opportunity to 
participate in communal activities like other members 
of the community’. Respondents spoke about degrees 
of acceptance by alluding to ‘full’ as well as ‘partial’ 
acceptance of affected persons, emphasising that the 
symbolic meanings of leprosy (see section on connota-
tions) prevented people affected by leprosy from being 
fully accepted.
Although popular perception in Yorùbá communi-
ties portrays affected persons as permanently stigma-
tised because of their perceived infectivity and immoral 
behaviour, interviews conducted for this research 
revealed that not all people affected by leprosy have had 
negative social experiences. A synthesis of the views of 
community member participants identified five factors 
that combined to stimulate acceptance of affected people 
in Western Nigeria: (i) treatment with antileprosy drugs; 
(ii) a good moral character; (iii) a supportive family 
network; (iv) financial contribution or a means of liveli-
hood; and (v) contribution to community survival. These 
are briefly explained next.
Role of antileprosy treatment in acceptance
A dominant discourse was that treatment with antileprosy 
drugs was a prominent trigger of acceptance in Yorùbá 
communities, which is shown in the following quote:
It is possible to regain full acceptance when one has been 
treated for leprosy. Using myself as an example, I was 
shunned before I received treatment for leprosy. No one 
invited me to participate in family or communal activities 
because they thought I would infect them with leprosy. But 
after I was treated and discharged from MDT, they have 
welcomed me back into the family. I was also recalled by 
the community. Now we all participate together whenever 
there are ceremonies such as marriages (Female, Food ven-
dor affected by leprosy).
This extract highlights the willingness of communities 
to accept those who have completed MDT, thus negating 
the view that leprosy was permanently stigmatised in 
Western Nigeria. Analysis of interview transcripts identi-
fied the emergence of a ‘new narratives of acceptance’ 
or possible life course available to persons with visible 
impairment and foot ulcers. The alternative accounts 
suggest that the people affected by leprosy in Western 
Nigeria have diverse life courses, allowing individuals 
to create new narratives to counteract existing cultural 
narratives that serve to marginalise them. The new narra-
tives of acceptance build on four of five factors listed 
earlier: family support, financial contribution, a means 
of livelihood and a unique contribution to the survival of 
the community.
Family support
Our findings show that Yorùbá families had strong recip-
rocal bonds of kinship towards their members. Families 
upheld their obligations to relatives affected by leprosy 
despite the stereotypes of marginality in the general 
community by assisting affected persons to manage their 
lives in practical ways. Most individuals affected by leprosy 
described how they were supported by families from the 
moment of diagnosis through periods of treatment until 
after their discharge from treatment. Communal accept-
ance was however contingent on family acceptance:
Community acceptance depends on family acceptance. 
It persuades the community that the affected person has 
the backing of people fighting for her or his welfare…If 
the family performs its duty, the community will accept the 
affected person back despite their deformity. If the fami-
ly welcomes the person, the community is more likely to 
re-accept them too (Male, Health worker affected by lep-
rosy).
Moral character
While the previous quote underlined the role of family 
support in communal acceptance, community members 
also emphasised that only people with good moral char-
acters were reaccepted by their families, implying that 
although families may be willing to accept affected 
persons, nonetheless, families can choose to neglect indi-
viduals with objectionable characters.
roles of financial contribution and livelihood
Respondents acknowledged that for acceptance by the 
community, equally as important as family acceptance 
and moral character were money and a source of liveli-
hood. A typical reference to the significance of financial 
contribution and livelihood in facilitating acceptance is 
as follows:
Those who have a means of survival are accepted back in 
the community. Once they can contribute financially to 
the community, they’ll be accepted. You know ‘money is 
the beacon of the heart’s decisions’ (Owó ni ìmợ́ràn ọkàn): 
meaning money facilitates the resolution of complex prob-
lems. If they have money, they will be highly regarded by 
the community. If they have some change (i.e. money), 
they will have a voice in the family and community. Those 
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who don’t have money are not reckoned with…even if they 
don’t have a stigmatizing disease (Female, Trader affected 
by leprosy).
The combination of money, a source of livelihood and 
financial contribution in the same account highlights 
that the importance of ‘ability to contribute’ to family 
and community needs to acceptance rather than the 
possession of money or a source of livelihood per se.
Our analysis has, thus far, focused on acceptance of 
affected individuals by families or the community. We 
now illustrate how groups of affected persons regained 
acceptance through their unique contribution to Yorùbá 
society.
Contribution to community survival
People affected by leprosy were barred from the markets 
in Yorùbá towns between the 1930s and 1960s due to the 
belief that they would infect the public with leprosy. This 
prohibition was repealed in the 1970s following public 
awareness of the curability and low infectivity of leprosy. 
Many respondents commented how affected persons 
earned the right to trade in Yorùbá markets due to the 
exceptional quality of farm products harvested from 
leprosy settlements and sold in the general markets. 
The unique advantage conferred by the superiority of 
their products thus triggered the collective acceptance 
of affected people in many Yorùbá towns. Asked about 
differences in community attitude towards people 
affected by leprosy today compared with 50 years earlier, 
one respondent claimed the following:
To answer your question, yes, there is a positive change in 
public attitude to leprosy compared to say 40 to 50 years 
ago, when the public refused to trade with affected people 
or prevented them from selling in the market place. But 
today the ban on trading or mixing with affected people 
has been lifted and lorries now go into leprosy settlements 
to transport farm produce to the markets. People are keen 
to trade with people who have leprosy today because they 
recognise most affected persons who come to the markets 
have been treated and cured and do not pose a risk of 
transmitting the disease (Male, Traditional healer).
The above account reveals the increasing contempo-
rary acceptance of people affected by leprosy and under-
lines the importance of public awareness for stimulating 
acceptance of affected people for their contribution to 
community development. The account also emphasises 
how practical considerations (contribution to food secu-
rity in Yorùbá towns) facilitated the collective inclusion of 
those affected by leprosy into the community.
dIsCussIon
Even though leprosy has been associated with stigmati-
sation throughout history, there are variations in how 
people affected by leprosy are stigmatised around the 
world. Nancy Waxler52 and Zachary Gussow53 contend 
that stigma is closely linked to historical and sociocul-
tural circumstances in which leprosy is found. Our study 
therefore adopted a qualitative, retrospective narrative 
life course approach to understand how leprosy shaped 
the lives of affected persons in Western Nigeria. We also 
drew on Yang et al’s (2014) concept of moral status,41 42 
Corrigan et al’s theory of structural discrimination40 and 
Link’s and Phelan’s concept of stigma34 to deepen social 
understandings of leprosy and responses to stigma. 
Following Yang et al, the initial paragraphs of our results 
section revealed how a moral association of leprosy 
and its deformity with intense shame and immoral 
behaviour was discrediting to the Yorùbá identity. The 
perception of leprosy as a symbolic problem that threat-
ened communal survival generated public avoidance 
and exclusion of affected persons. This finding echoes 
aspects of Ronald Barrett’s narrative study of leprosy 
in Northern India that showed how stigma led family 
members to expel relatives with deformities to isolated 
colonies and distant towns to beg for their survival.3 
Barrett argued that the severity and intractability of 
leprosy stigma activated a cycle of concealment of the 
disease and treatment avoidance that, in turn, produced 
physical deformities and social discrimination that 
worsened the economic chances of people affected 
by leprosy. According to Barrett, the combination of 
visible deformities and begging for survival informed 
the cultural beliefs and stereotypes that have become 
the sources of stigma in India. On the contrary, other 
sources towhich researchers54 have attributed stigma 
include religious beliefs that consider leprosy to be a 
punishment forsins55, the treatment of leprosy inspecial 
hospitals53, and discriminatory laws.
Reverting to Western Nigeria, it is concerning that 
despite the seeming understanding of the biomedical 
causes and transmission of leprosy by sections of the 
Yorùbá community, people aged >40 years still believe 
in supernatural causation of leprosy, high infectivity and 
spread by casual contact with leprosy-affected people. 
While cultural beliefs and practices may perpetuate the 
views held by those >40 years of age, we contend that 
the discriminatory ideas endorsed by and disseminated 
through institutional policies and social practices (using 
religious teachings, primary school books and public 
health campaigns) also contributed to shaping contem-
porary views and responses to leprosy in Western Nigeria. 
Specifically, the equation of the mode of transmission 
of leprosy with that of smallpox,29 and the suggestion 
that leprosy is spread through casual contact with open 
wounds or sharing articles with affected persons27 may 
have transformed leprosy from an ‘inherited disease’ to 
a ‘contagious disease’. These findings are similar to the 
introduction of stigma to northern Tanzania by Western 
public health educators in 1960s and 1970s, an interven-
tion that instigated schoolchildren to avoid contact or 
sharing food with affected people.56 While leprosy was an 
unremarkable disease in northern Tanzania before the 
intervention, children later opposed the idea of affected 
persons living with relatives for fear that they would 
transmit leprosy to family members.
 o
n
 8 M
arch 2019 by guest. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2018-001250 on 7 March 2019. Downloaded from 
10 Ebenso B, et al. BMJ Glob Health 2019;4:e001250. doi:10.1136/bmjgh-2018-001250
BMJ Global Health
We propose that although the Yorùbá people stigma-
tised leprosy prior to the arrival of Western missionaries, 
they nevertheless viewed leprosy as a disease transmitted 
among families who had a genetic disposition to leprosy, 
and not generally affecting others. In that sense, the 
Yorùbá were not afraid of catching leprosy from affected 
persons except when marriage with affected families 
was contemplated. However, after the introduction of 
medical ideas of infectivity, leprosy was transformed 
from an ‘inherited disease’ of a few families to a ‘general 
threat’ that was transmissible by casual contact. The idea 
of high infectivity thus amplified the dread of leprosy 
and prompted widespread avoidance of affected people 
because of the danger they now posed to society. It is easy 
to see how the circulation of ‘authoritative’ ideas of infec-
tivity of leprosy and its link to smallpox may have influ-
enced contemporary Yorùbá perception of causation and 
spread of leprosy. The continuing gap in understanding 
of the causes and transmission of leprosy presents a good 
opportunity for the leprosy control service to work with 
cultural, religious and educational institutions to de-em-
phasise the symbolic interpretation of leprosy in Western 
Nigeria and counteract the prevailing misconceptions. 
This should include reviewing and updating primary 
school curriculum, and Christian religious teachings 
identified as the underlying sources of stigma in Western 
Nigeria.
Three other issues remain in relation to recognising 
the symptoms of leprosy and seeking prompt treat-
ment. First, the communal identification of leprosy 
by visible deformities prevents individuals and fami-
lies from identifying early symptoms of the illness as 
leprosy. This has implications for help-seeking when such 
portrayal of leprosy is combined with belief in supernat-
ural causation, leading to delays typically of many years 
between initial perception of symptoms and presenta-
tion to a leprosy hospital for diagnosis and treatment. 
Such delays can undoubtedly frustrate the achievement 
of the zero disability target of the WHO. Second, the 
Yorùbá conception of cure as ‘complete resolution of all 
symptoms and signs of leprosy’ perpetuates the idea of 
incurability of leprosy. Third, there are concerns about 
gender difference in help-seeking, as women were more 
likely to delay reporting for diagnosis and treatment. 
Other studies have highlighted that stigma dispropor-
tionately affects women in endemic countries with strong 
traditions, causing poor access to education and health 
services, and socioeconomic dependence, creating inferi-
ority, marital rejection and isolation.57–60 We recommend 
a two-pronged approach to addressing long delays in 
Western Nigeria: (i) the leprosy control service should 
emphasise the message that ‘even a single lesion can be 
a sign of leprosy and requires urgent attention to mini-
mise the risk of impairment’ rather than waiting for the 
person to develop several patches or visible deformities 
before referral is initiated and (ii) a gender-specific inter-
vention to support and enable early reporting for diag-
nosis and treatment.
Contrary to the portrayal of leprosy as a social blemish 
that evokes permanent exclusion in Western Nigeria, this 
study revealed that stigmatisation of persons affected by 
leprosy is changing. There is enough evidence to show 
that a combination of factors (completion of MDT, 
good moral character, family support, livelihoods and 
contribution to food security) enables people affected 
by leprosy to resist marginalisation in Western Nigeria. 
These factors empower those affected by leprosy to meet 
social-transactional obligations in their community, thus 
raising their social status and facilitating their inclusion 
as fully viable members of society.61
Compared with overt exclusionary attitudes in 
northern India and in Western Nigeria, the context in 
Mali presents a more benign social response to leprosy. 
Drawing on archival sources and life history interviews 
with former patients in Mali, Eric Silla62 showed how 
contact with European institutions and other historical 
events influenced perceptions of leprosy and the identity 
of those affected by leprosy. Silla’s ethnographic research 
revealed that although people affected by leprosy were 
shunned in precolonial Mali, villagers never expelled 
those who had skin patches. People with deformities or 
ulcers were given a separate hut in family compounds 
and in certain regions of Mali, they were prohibited from 
eating from the same bowl as others. Physical deformi-
ties excluded people from work and marriage (two key 
elements of social identity in agrarian societies), but 
leprosy never fully obscured all of one’s other identities. 
Identities rooted in leprosy were remarkably transformed 
in colonial and postcolonial Mali. For instance, the policy 
of forceful segregation of patients in leprosaria and the 
separation of leprosy treatment from other healthcare 
services transformed all leprosy patients (whether they 
had deformities or not) into what Silla called ‘social 
lepers’. In other words, medical treatment of leprosy in 
colonial Mali generated widespread social stigma, leading 
some patients to seek treatment in secret (Silla 1998, 
p156). To counter institutional discrimination, patient 
communities established around government leprosaria 
provided a foundation for collective social identities 
and the emergence of patient activists. Compared with 
the deprivation from social and economic participation 
experienced in rural Mali, patient activists used opportu-
nities provided by their newfound communities to exert 
greater control over their lives.
Several historical events strengthened their destigmati-
sation efforts of people affected by leprosy and their quest 
to define their collective identity in Mali. These included 
the introduction of mass treatment with Dapsone by the 
WHO in 1951, followed by a call for the abolition of lepro-
saria and their replacement with mobile leprosy dispen-
saries (Silla 1998, p109). Equally important were Mali’s 
attainment of political independence in 1960 and the 
growth of autonomous associations of Malians who were 
keen to participate in the new civil society. The passion 
for political activism subsequently led to the launch of 
a national association of persons affected by leprosy in 
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1991, and to a national protest following a presidential 
candidate’s insensitive rhetoric against people affected 
by leprosy. The association has facilitated the redress of 
injustices against people affected by leprosy including 
securing transparency over financial grants to people 
affected by leprosy and garden plots in the national 
capital, Bamako.
ConClusIon
From the foregoing, we conclude that the goal of global 
zero stigma and discrimination will remain unachievable 
without better understanding of the cultural conceptu-
alisations of leprosy, the sources and underlying drivers 
of stigma in each of the contexts where leprosy remains 
problematic. Ethnographic studies that explore the link-
ages between broader historical events and individual 
experiences of leprosy are essential for comprehending 
how stigma may have changed/is changing (or not) over 
time, and for developing and targeting context-specific 
interventions. Failure to identify the sources of stigma 
can encourage victim blaming of individuals and commu-
nity members for stigmatising beliefs and practices. Our 
study identified the sources of stigma in Western Nigeria 
as societal-level factors such as institutional policies, legis-
lations and practices that shaped community perceptions 
and social reactions to leprosy. Moreover, we identified a 
blend of stigma reduction interventions including antile-
prosy treatment, psychological and social support from 
families, and poverty reduction initiatives and involve-
ment in community development initiatives. Finally, the 
historical events in Mali underline the importance of 
patient communities and of collective social action for 
changing social attitudes and redressing injustices against 
people affected by leprosy.
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